For a really good summary of what drug manufacturers big and small are doing to develop Ebola vaccines and drugs to stem the growing catastrophe of the Ebola virus outbreak, read this article by Scott Gottlieb, MD.
He discusses the recent donation of 1000 doses of a vaccine developed by the Canadian government, the status of the ZMAPP drug given to Americans Dr. Kent Brantly and Nancy Writebol, vaccine efforts by Danish firm Bavarian Nordic, phase I clinical trials being planned for a vaccine manufactured by GlaxoSmithKline, and the unfortunate discontinuation of an Ebola treatment made by Sarepta because of a lack of funding.
Disclosure – the author owns 10 shares of Sarepta (NASDAQ)
Leave a Reply